Unlock instant, AI-driven research and patent intelligence for your innovation.

ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer

a polypeptide and cancer technology, applied in the field of icbp90 polypeptides and its fragments, can solve problems such as emergence of resistance to drugs

Inactive Publication Date: 2006-12-14
INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM)
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0016] A recent technique called a “simple hybridsystem has been used, which allows DNAc clones coding for the proteins binding to this specific DNA of certain sequences to be isolated. This system has a double advantage as it is able not only to reveal DNA-protein interaction in vivo in yeast, but also to give direct access to complementary DNAs (cDNA) coding for the candidate proteins having a transcription factor activity. This system is mainly based on the construct of a test yeast strain according to the principle developed by Wang and Reed (1993). This yeast strain enables DNAc banks to be screened by demonstrating DNA-protein interaction in vivo through activation of a reporter gene integrated within the genome of the test yeast. BRIEF SUMMARY OF THE INVENTION

Problems solved by technology

Nevertheless, one of the major problems encountered in the present anticancer treatments using inhibitors of topoisomerases is the emergence of a resistance to drugs (Kubo et al., 1995).

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
  • ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
  • ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer

Examples

Experimental program
Comparison scheme
Effect test

example 1

Evidence of a New Binding Protein for the ICB Sequence

[0143] 1.1 Reporter Construction for the Screening of the Library

[0144] The simple hybrid system is a powerful technique for detecting, in vivo, in yeast the interaction of proteins with specific DNA sequences when screening cDNA libraries. This technique allows you to evaluate directly cDNA corresponding to the protein to be linked. Several studies using this technique resulted in the identification of novel proteins. The protocols are well described by Inouye et al. (1994) and Wang and Reed (1993).

[0145] Briefly, the following oligonucleotides have been synthesized:

(SEQ ID NO:15)5′-AATTCGGGGCGGGGCCGGGGCGGGCCCGGGGCGGGGCT-3′(SEQ ID NO:16)5′-CTAGAGCCCCGCCCCGGCCCCGCCCCGGCCCCGCCCCGG-3′

[0146] These nucleotides were then hybridised. According to the documentation of the manufacturer (Clontech, Palo Alto, Calif.), the reporter construct targeted possesses three copies in tandem of the ICB2 sequence (ICB2X3). As mentioned above, on...

example 2

Characterisation of the ICBP90 Protein

[0157] 2.1. Synthesis of Antibodies

[0158] Mouse monoclonal antibodies were synthesized in our laboratory by injection of ICBP-59 protein using traditional methods (Brou et al., 1993); the protein was purified beforehand by a fusion GST system. Two monoclonal antibodies from 1RC1C-10 and 1RC1H-12 were selected for their ability to detect the ICBP-59 endogenous protein; their specificity was demonstrated in both Western blotting and immunocytochemistry experiments. Before use, the antibodies were purified on a DEAE-cellulose column (DE52, Whatmann) from ascites fluid.

[0159] 2.2 Detection of the Endogenous Protein by Western Blotting

[0160] To detect endogenous ICBP-59 protein, we first used 1RC1C-10 in a Western blot (0.4 μg / ml 1RC1C-10 monoclonal antibodies) of nuclear extracts from confluent and proliferating HeLa cells (FIG. 1). COS-1 and HeLa cells were cultivated as previously described (Brou et al., 1993; Gaub et al., 1998; Rochette-Egly ...

example 3

Isolation and Characterization of Gene ICBP90

[0185] 3.1. Material and Methods

[0186] 3.1.1. Construction and Screening of a Human Placental Genomic Library

[0187] After partial digestion with MboI enzyme, the placental genomic DNA was split up according to size on a 10 to 40% sucrose gradient. Fifteen kb DNA Fragments were ligated in a λGEM 12 vector previously digested with BamHI (Promega, Madison Wis., USA). After packaging, phage λ particles were assayed on TAP 90 cells. The genomic library contains 3.106 plaque-forming units (pfu). 106 clones were spread out for analysis. A 620 bp probe corresponding to a 5′ terminal extremity of the ICBP90 cDNA used for the screening was labelled with α32P-dCTP by a random priming method (Sambrook et al., 1989). The labelled probe is used according to a classic on plaque hybridisation protocol to screen the genomic library (Sambrook et al., 1989). Hybridisation was achieved at 68° C. in 5× SSC (15 mM NaCl, 1.5 mM sodium citrate pH 7.0), 5 × De...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention concerns a novel ICBP90 (Inverted CCAAT box binding protein 90) and its fragments, polynucleotides coding for said polypeptides and specific antibodies directed against said polypeptides. The invention also concerns methods and kits for diagnosing cell proliferation and compounds useful as medicine for preventing and / or treating pathology involving cell proliferation and in particular cancer.

Description

[0001] This application is a divisional of application Ser. No. 10 / 019,071, which is a National Stage application of PCT / FR00 / 01747, filed Jun. 22, 2000, which claims priority from French patent application FR 99 07935, filed Jun. 22, 1999. The entire contents of each of the aforementioned applications are incorporated herein by reference.[0002] The present invention relates to a new ICBP90 polypeptide and its fragments, to the cloning of cDNA and polynucleotides coding for said polypeptides, to cloning and / or expression vectors including said polynucleotides, cells transformed by said vectors and specific antibodies directed against said polypeptides. The invention also relates to methods and kits for diagnosing cancers, to a method and kit for screening ligands of the polypeptides of the invention and of compounds which may be used as a drug for prevention and / or treatment of cancers. [0003] DNA topoisomerases are highly preserved nuclear proteins during evolution, the main role o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/68G01N33/574C07H21/04C12P21/06C07K14/82C07K16/30A61K38/00A61K47/48A61K48/00A61P35/00C07K16/18C12N15/12C12Q1/6886
CPCA61K38/00A61K47/48538A61K48/00C12Q2600/136C12Q1/6886Y10S530/827Y10S530/828C07K16/18A61K47/6843A61P35/00
Inventor BRONNER, CHRISTIANHOPFNER, RAPHAELMOUSLI, MARCJELTSCH, JEAN-MARCLUTZ, YVESOUDET, PIERRE
Owner INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM)